FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386878727> ?p ?o ?g. }

• W4386878727 abstract "BACKGROUND: The existence and prognosis of T1LG (T1 low-grade) bladder cancer is controversial. Also, because of data paucity, it remains unclear what is the clinical history of bacillus Calmette-Guérin (BCG) treated T1LG tumors and if it differs from other NMIBC (non-muscle-invasive bladder cancer) representatives. The aim of this study was to analyse recurrence-free survival (RFS) and progression-free survival (PFS) in patients with T1LG bladder cancers treated with BCG immunotherapy.METHODS: A multi-institutional and retrospective study of 2510 patients with Ta/T1 NMIBC with or without carcinoma in situ (CIS) treated with BCG (205 T1LG patients) was performed. Kaplan-Meier estimates and log-rank test for RFS and PFS to compare the survival between TaLG, TaHG, T1LG, and T1HG NMIBC were used. Also, T1LG tumors were categorized into EAU2021 risk groups and PFS analysis was performed, and Cox multivariate model for both RFS and PFS were constructed.RESULTS: The median follow-up was 52 months. For the T1LG cohort, the estimated RFS and PFS rates at 5-year were 59.3% and 89.2%, respectively. While there were no differences in RFS between NMIBC subpopulations, a slightly better PFS was found in T1LG NMIBC compared to T1HG (5-year PFS; T1LG vs. T1HG: 82% vs. 89%; P<0.001). A heterogeneous classification of patients with T1LG NMIBC was observed when EAU 2021 prognostic model was applied, finding a statistically significant worse PFS in patients classified as high-risk T1LG (5-year PFS; 81.8%) compared to those in intermediate (5-year PFS; 93,4%), and low-risk T1LG tumors (5-year PFS; 98,1%).CONCLUSIONS: The RFS of T1LG was comparable to other NMIBC subpopulations. The PFS of T1LG tumors was significantly better than of T1HG NMIBC. The EAU2021 scoring model heterogeneously categorized the risk of progression in T1LG tumors and the high-risk T1LG had the worst PFS." @default.
• W4386878727 created "2023-09-21" @default.
• W4386878727 creator A5011013432 @default.
• W4386878727 creator A5011884678 @default.
• W4386878727 creator A5012396827 @default.
• W4386878727 creator A5013794118 @default.
• W4386878727 creator A5013947563 @default.
• W4386878727 creator A5016314807 @default.
• W4386878727 creator A5017937306 @default.
• W4386878727 creator A5019968775 @default.
• W4386878727 creator A5024457051 @default.
• W4386878727 creator A5024662180 @default.
• W4386878727 creator A5025441151 @default.
• W4386878727 creator A5027982787 @default.
• W4386878727 creator A5032034423 @default.
• W4386878727 creator A5034600466 @default.
• W4386878727 creator A5037195812 @default.
• W4386878727 creator A5038102022 @default.
• W4386878727 creator A5038866794 @default.
• W4386878727 creator A5040296751 @default.
• W4386878727 creator A5046580566 @default.
• W4386878727 creator A5057962494 @default.
• W4386878727 creator A5062144284 @default.
• W4386878727 creator A5063109707 @default.
• W4386878727 creator A5064289050 @default.
• W4386878727 creator A5064914239 @default.
• W4386878727 creator A5067009915 @default.
• W4386878727 creator A5070099238 @default.
• W4386878727 creator A5073181265 @default.
• W4386878727 creator A5074919720 @default.
• W4386878727 creator A5075155205 @default.
• W4386878727 creator A5079401169 @default.
• W4386878727 creator A5083351538 @default.
• W4386878727 creator A5083962277 @default.
• W4386878727 creator A5084326149 @default.
• W4386878727 creator A5086567320 @default.
• W4386878727 creator A5087280573 @default.
• W4386878727 creator A5090507727 @default.
• W4386878727 date "2023-09-01" @default.
• W4386878727 modified "2023-10-07" @default.
• W4386878727 title "Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy" @default.
• W4386878727 cites W1850152041 @default.
• W4386878727 cites W1965422756 @default.
• W4386878727 cites W1970969821 @default.
• W4386878727 cites W1980801853 @default.
• W4386878727 cites W1983910036 @default.
• W4386878727 cites W1985388580 @default.
• W4386878727 cites W2002045993 @default.
• W4386878727 cites W2017306423 @default.
• W4386878727 cites W2092934604 @default.
• W4386878727 cites W2116299167 @default.
• W4386878727 cites W2415416460 @default.
• W4386878727 cites W2443056117 @default.
• W4386878727 cites W2609464379 @default.
• W4386878727 cites W3092815757 @default.
• W4386878727 cites W3109689102 @default.
• W4386878727 cites W3120001159 @default.
• W4386878727 cites W3198719997 @default.
• W4386878727 cites W4229735925 @default.
• W4386878727 cites W4280579488 @default.
• W4386878727 cites W4283021039 @default.
• W4386878727 cites W4285606368 @default.
• W4386878727 doi "https://doi.org/10.23736/s2724-6051.23.05418-6" @default.
• W4386878727 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37728495" @default.
• W4386878727 hasPublicationYear "2023" @default.
• W4386878727 type Work @default.
• W4386878727 citedByCount "0" @default.
• W4386878727 crossrefType "journal-article" @default.
• W4386878727 hasAuthorship W4386878727A5011013432 @default.
• W4386878727 hasAuthorship W4386878727A5011884678 @default.
• W4386878727 hasAuthorship W4386878727A5012396827 @default.
• W4386878727 hasAuthorship W4386878727A5013794118 @default.
• W4386878727 hasAuthorship W4386878727A5013947563 @default.
• W4386878727 hasAuthorship W4386878727A5016314807 @default.
• W4386878727 hasAuthorship W4386878727A5017937306 @default.
• W4386878727 hasAuthorship W4386878727A5019968775 @default.
• W4386878727 hasAuthorship W4386878727A5024457051 @default.
• W4386878727 hasAuthorship W4386878727A5024662180 @default.
• W4386878727 hasAuthorship W4386878727A5025441151 @default.
• W4386878727 hasAuthorship W4386878727A5027982787 @default.
• W4386878727 hasAuthorship W4386878727A5032034423 @default.
• W4386878727 hasAuthorship W4386878727A5034600466 @default.
• W4386878727 hasAuthorship W4386878727A5037195812 @default.
• W4386878727 hasAuthorship W4386878727A5038102022 @default.
• W4386878727 hasAuthorship W4386878727A5038866794 @default.
• W4386878727 hasAuthorship W4386878727A5040296751 @default.
• W4386878727 hasAuthorship W4386878727A5046580566 @default.
• W4386878727 hasAuthorship W4386878727A5057962494 @default.
• W4386878727 hasAuthorship W4386878727A5062144284 @default.
• W4386878727 hasAuthorship W4386878727A5063109707 @default.
• W4386878727 hasAuthorship W4386878727A5064289050 @default.
• W4386878727 hasAuthorship W4386878727A5064914239 @default.
• W4386878727 hasAuthorship W4386878727A5067009915 @default.
• W4386878727 hasAuthorship W4386878727A5070099238 @default.
• W4386878727 hasAuthorship W4386878727A5073181265 @default.
• W4386878727 hasAuthorship W4386878727A5074919720 @default.
• W4386878727 hasAuthorship W4386878727A5075155205 @default.
• W4386878727 hasAuthorship W4386878727A5079401169 @default.
• W4386878727 hasAuthorship W4386878727A5083351538 @default.
• W4386878727 hasAuthorship W4386878727A5083962277 @default.

• next